Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPACITY: CAE and LAI for Chronic Psychotic Disorders in Tanzania
NCT04327843Phase 3Completed
- Sponsor
- Case Western Reserve University
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of haloperidol in schizophrenia, schizoaffective disorder, sponsored by Case Western Reserve University. Started Nov 2019; status: completed.
02
Drugs
haloperidol
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT04327843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04327843.